Comparison · NCT01070095-4a30f878
Baseline Period vs Intervention Period: Medication Escalations
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Baseline Period vs Intervention Period: Medication Escalations. Trial comparisons, record NCT01070095-4a30f878. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01070095-4a30f878
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.128 | 0.107 | 0.152 | wilson | |
| Risk in group 2 | 0.131 | 0.111 | 0.155 | wilson | |
| Risk difference, group 1 minus group 2 | -0.00375 | -0.0355 | 0.0282 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.971 | 0.76 | 1.24 | log | |
| Odds ratio, group 1 over group 2 | 0.967 | 0.73 | 1.28 | log | |
| Number needed to treat, for one fewer participant with the outcome on Baseline Period than on Intervention Period | 267 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Baseline Period | 12 months pre-intervention | 106 | 830 | OG000 |
| Group 2 | Intervention Period | 12 months post-intervention (eAAPS) | 117 | 890 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Medication Escalations
- Description
The number of patients with escalation of controller therapy Predictor model to include: clinic, appointment provider practitioner type, prior objective diagnosis of asthma, documented physician diagnosis of asthma, presenting complaint type, billing physician (most responsible physician/other), previous emergency department (ED) visits/hospitalizations for asthma, and current asthma control
- Time frame
- 24 months
- Population
- In the measuring therapy escalation, we eliminated visits in which patients had had a controller medication escalated within the last three months (the typical duration of a therapeutic trial)
Source ClinicalTrials.gov
Trial
- Title
- The Electronic Asthma Action Plan System for Implementation in Primary Care
- NCT number
- NCT01070095
- Phases
- NA
- Conditions
- Asthma
- Interventions
- Electronic Asthma Action Plan System
- Lead sponsor
- Unity Health Toronto
- Results first posted
- 2019-09-13
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01070095?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01070095-4a30f878